VAC protocol

chemotherapy protocol consisting of above cpds; used in gynecologic neoplasms

Also Known As:

VDC protocol

Networked: 5 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VAC protocol: 5
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VAC protocol: 5
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VAC protocol: 5
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Halogenated Hydrocarbons: 42
    - Mustard Compounds: 3
      - Nitrogen Mustard Compounds: 2
        Phosphoramide Mustards: 5
        Cyclophosphamide: 25473
        VAC protocol: 5
- Organophosphorus Compounds: 300
  - Phosphoramides: 8
    - Phosphoramide Mustards: 5
      - Cyclophosphamide: 25473
        VAC protocol: 5
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Indole Alkaloids: 200
    - Secologanin Tryptamine Alkaloids: 81
      - Vinca Alkaloids: 463
        Vincristine: 9251
        VAC protocol: 5
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        VAC protocol: 5
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        VAC protocol: 5
  - 3-Ring Heterocyclic Compounds
    - Dactinomycin: 2073
      - VAC protocol: 5
Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Dactinomycin: 2073
      - VAC protocol: 5
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Dactinomycin: 2073
      - VAC protocol: 5

Experts

1.	Alvarez, Francisco J: 1 article (11/2013)
2.	Couto, Guillermo: 1 article (11/2013)
3.	Hosoya, Kenji: 1 article (11/2013)
4.	Kisseberth, William: 1 article (11/2013)
5.	Lara-Garcia, Ana: 1 article (11/2013)
6.	Gagnon, Raymonde F: 1 article (05/2004)
7.	Gill, Kathryn: 1 article (05/2004)
8.	Gooderham, Peter A: 1 article (05/2004)

Related Diseases

1.	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 08/01/1996 - "The EPO-VAC protocol was initiated to study 1) the efficacy of adding a cisplatin regimen (EPO) to VAC alone (the previous standard of care) and 2) the effect of replacing bleomycin with etoposide in the treatment of pediatric endodermal sinus tumors. "
2.	Renal Insufficiency (Renal Failure) 05/01/2004 - "Two weeks after the surgical induction of renal failure, CRF mice, together with normal and sham-operated control mice, were submitted to a standard 24-day VAC protocol. "
3.	Neoplasm Metastasis (Metastasis) 01/01/1996 - "In cases of metastases additionally a chemotherapy (VAC protocol) is indicated. "
4.	Hemangiosarcoma (Angiosarcoma) 11/01/2013 - "VAC protocol for treatment of dogs with stage III hemangiosarcoma."
5.	Dysgerminoma 01/01/1996 - "For all other dysgerminoma adjuvant chemotherapy, VAC protocol, and chemotherapy according the the BEP protocol for non-dysgerminoma is recommended. "

Related Drugs and Biologics

1.	Etoposide (VP 16)
2.	Cisplatin (Platino)
3.	Bleomycin (Blenoxane)
4.	Vincristine (Oncovin)
5.	Methotrexate (Mexate)
6.	Fluorouracil (Carac)
7.	Doxorubicin (Adriamycin)
8.	Cyclophosphamide (Cytoxan)
9.	salicylhydroxamic acid (SHAM)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Adjuvant Chemotherapy
3.	BEP protocol
4.	CMF regimen